viewFeedback PLC

Feedback confirms potential equity raise to fund Bleepa development

Feedback plans to launch Bleepa at the NHS Expo in Manchester in early September.

Feedback PLC -
Doctors risk litigation by communicating about their patients over WhatsApp

Feedback PLC (LON:FDBK) has confirmed online speculation that it is considering an equity raise to fund the development of its clinical message app, Bleepa.

The medical imaging technology firm said it is “working on completing a placing of new shares” but stressed that there can be “no certainty” that such a fundraising will be held.

Feedback plans to launch Bleepa at the NHS Expo in Manchester in early September.

Bleepa is an encrypted medical messaging app that can be used on smartphones, tablets and desktops, allowing clinicians to communicate with other team members securely.

According to an article published in BMJ Innovations, 97% of doctors routinely communicate about their patients over WhatsApp but this leaves users and hospitals exposed to the risk of litigation.

Quick facts: Feedback PLC

Price: 1.1602 GBX

Market: LSE
Market Cap: £6.26 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...



Full interview: Feedback PLC gearing up for big launch of its clinical...

Feedback PLC's (LON:FDBK) Tom Oakley discusses with Proactive Lonodn's Andrew Scott the upcoming commercial launch of their clinical messaging product Bleepa. Oakley expects it to change the way medical images are communicated in everyday clinical practice on mobile devices and laptops. He...

on 15/8/19

2 min read